VHB Life Sciences Limited offers Tamoxifen Citrate Tablets. VHB Life Sciences Limited has WHO GMP certified facility as well as INVIMA approved facility. Tamoxifen Citrate Tablets are available in packing of ten strips of ten tablets. These tablets are used in adjuvant therapy in axillary node-negative breast cancer following surgical resection, adjuvant therapy in axillary node-positive breast cancer in postmenopausal women following surgical resection, metastatic breast cancer in women and men. Tamoxifen Citrate Tablets are available with the brand name Moxifen.
